-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47

Benzinga·08/11/2026 13:40:34
Listen to the news
Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises the price target from $45 to $47.